WO2001060994A1 - Method and apparatus for destroying dividing cells - Google Patents

Method and apparatus for destroying dividing cells Download PDF

Info

Publication number
WO2001060994A1
WO2001060994A1 PCT/IB2001/000202 IB0100202W WO0160994A1 WO 2001060994 A1 WO2001060994 A1 WO 2001060994A1 IB 0100202 W IB0100202 W IB 0100202W WO 0160994 A1 WO0160994 A1 WO 0160994A1
Authority
WO
WIPO (PCT)
Prior art keywords
electric field
dividing cells
living tissue
cleavage
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2001/000202
Other languages
English (en)
French (fr)
Inventor
Yoram Palti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA2400526A priority Critical patent/CA2400526C/en
Priority to US10/204,334 priority patent/US7333852B2/en
Priority to JP2001560365A priority patent/JP5280600B2/ja
Priority to EP01906036A priority patent/EP1259596A4/en
Priority to US12/199,498 priority patent/USRE43618E1/en
Priority to AU33998/01A priority patent/AU3399801A/en
Application filed by Individual filed Critical Individual
Publication of WO2001060994A1 publication Critical patent/WO2001060994A1/en
Anticipated expiration legal-status Critical
Priority to US11/111,236 priority patent/US7805201B2/en
Priority to US11/111,439 priority patent/US7565205B2/en
Priority to US11/111,393 priority patent/US7599745B2/en
Priority to US11/318,702 priority patent/US7565206B2/en
Priority to US11/422,641 priority patent/US7599746B2/en
Priority to US12/146,918 priority patent/US8175698B2/en
Priority to US12/190,886 priority patent/US7890183B2/en
Priority to US12/958,623 priority patent/US8447395B2/en
Priority to US13/428,887 priority patent/US8447396B2/en
Priority to US13/782,418 priority patent/US9039674B2/en
Priority to US13/782,579 priority patent/US9056203B2/en
Priority to US14/731,903 priority patent/US9440068B2/en
Priority to US15/231,734 priority patent/US9750934B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/205—Applying electric currents by contact electrodes continuous direct currents for promoting a biological process
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00613—Irreversible electroporation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/147—Electrodes transferring energy by capacitive coupling, i.e. with a dielectricum between electrode and target tissue

Definitions

  • the present invention relates to selective destruction of Uy dividing cells and,
  • cancers are characterized by an ability to transmit cancerous "seeds", including single cells or small cell clusters (metastasises), to new locations where the metastatic cancer cells grow into additional tumors.
  • the distinguishably frequent cell division of cancer cells is the basis for the effectiveness of existing cancer treatments, e.g., irradiation therapy and the use of various chemo-therapeutic agents. Such treatments are based on the fact that cells undergoing division are more sensitive to radiation and chemo-therapeutic agents than non-dividing dells. Because tumor cells divide much more frequently than normal cells, it is possible, to a certain extent, to selectively damage or destroy tumor cells by cells, it is possible, to a certain extent, to selectively damage or destroy tumor cells by
  • tissue renders treatments very traumatic to the patients and, often, patients are unable to
  • destroying tumor cells may be used in addition to or instead of conventional treatments.
  • the target tissue results in the destruction of both tumor cells and normal cells.
  • an electric field is applied for targeting selected cells to cause breakdown of the dielectric
  • the cells are selected on the basis of intrinsic or induced
  • the method of the '066 patent is therefore based on the assumption that the
  • electroporation threshold of tumor cells is sufficiently distinguishable from that of normal
  • microorganisms such as bacteria, mycoplasma, yeast, protozoa, and other single-celled cells
  • centrioles each cell contains 2
  • each chromosome is a chromosome
  • Microtubular spindles radiate from regions adjacent to
  • centrioles which are closer to their poles.
  • the centrioles have
  • chromosomes move toward the equator of the cell and align in the equatorial plane.
  • the cell begins to elongate along the axis of the pole; the pole-to-pole spindles also elongate.
  • Late anaphase occurs when the daughter chromosomes (as they are not called) each reach
  • cytokinesis begins as the cleavage furrow
  • late anaphase is the point at
  • the cell returns to interphase.
  • chromosomes to opposite poles of the cell along spindle fibers, followed by formation of a
  • Bacteria also divide by chromosome replication, followed by cell separation.
  • the present invention provides a new method and apparatus for selectively
  • present invention eliminate or control the growth of such living tissue or organisms.
  • a major use of the method and apparatus of the present invention is in treatment of
  • tumors by selective destruction of tumor cells with substantially no affect on normal tissue
  • cell may also refer to single-celled organisms (eubacteria, bacteria,
  • yeast protozoa
  • multi-celled organisms fungi, algae, mold
  • plants as or parts thereof
  • the method of the present invention enables
  • the method of the present invention causes minimal damage, if any, to normal tissue and, thus, reduces or
  • dividing state may have different shapes, e.g., spherical, ellipsoidal, cylindrical, "pancake"
  • cleavage furrow in late anaphase and telophase. This cleavage furrow is a slow
  • a cell or a group of cells When a cell or a group of cells are under natural conditions or environment, i.e., part of a living tissue, they are disposed surrounded by a conductive environment
  • tissue components may be frequency dependent
  • the tissue properties may be
  • Such cells include first and second sub-cells, namely, an "original” cell and a newly formed cell, that are connected by a cytoplasm "bridge” or "neck".
  • the currents include first and second sub-cells, namely, an "original” cell and a newly formed cell, that are connected by a cytoplasm "bridge” or "neck".
  • the field polarity is
  • an alternating electric field may be
  • pulses are applied to the organelles numerous times per second, enhancing the
  • organelles themselves and may collapse or break the organelles.
  • the electric potential applied to the tumor tissue is preferably rotated
  • Shielding can be any suitable application of electrodes. Shielding can be any suitable application of electrodes. Shielding can be any suitable application of electrodes. Shielding can be any suitable application of electrodes. Shielding can be any suitable application of electrodes. Shielding can be any suitable application of electrodes. Shielding can be any suitable application of electrodes. Shielding can be any suitable application of electrodes. Shielding can be any suitable application of electrodes. Shielding can be any combination of electrodes.
  • a conducting material such as copper, aluminum, steel, etc.
  • the field may be selectively targeted to specific regions, e.g.,
  • the field may be controlled by active means, for example, by applying
  • electric fields may be generated in the body by
  • the electrodes may be any suitable electrode that can be used to control the skin. If fields not associated with conductive currents are desired, the electrodes may be used to control the skin. If fields not associated with conductive currents are desired, the electrodes may be used to control the skin. If fields not associated with conductive currents are desired, the electrodes may be used to control the skin. If fields not associated with conductive currents are desired, the electrodes may be used to control the skin. If fields not associated with conductive currents are desired.
  • Localized internal fields may be produced by introducing
  • Electrodes into the living tissue e.g., by insertion through body cavities or by penetrating
  • Such organisms divide by the formation of a groove or cleft as described above.
  • a groove or cleft as described above.
  • Fig. 1 A- IE are simplified, schematic, cross-sectional, illustrations of various stages
  • FIGs. 2A and 2B are schematic illustrations of a non-dividing cell being subjected
  • Figs. 3 A, 3B and 3C are schematic illustrations of a dividing cell being subjected to
  • Fig 4 is a series of sequential microphotographic frames taken over a set period of
  • Fig. 5 is a series of sequential microphotographic frames illustrating a dividing cell
  • FIG. 1 A shows a cell 10 at its normal geometry, which may be
  • Figs. IB- ID show cell 10 during different conditions
  • the division process of cell 10 is characterized by a
  • the division process is characterized by a transient period during
  • Cell 10 includes intracellular organelles, e.g., a nucleus 30. Alternating
  • Electrodes 28 and 32 that may be attached externally to
  • a patient at a predetermined region, e.g., in the vicinity of a tumor being treated.
  • cell 10 is under natural conditions, i.e., part of a living tissue, it is disposed in a conductive
  • volume conductor consisting mostly of
  • Fig. 2A At higher frequencies, e.g., at
  • the membrane capacitance may short the
  • the electric field lines (or induced
  • the cu ⁇ ent flow pattern across cell 10 is generally uniform because, under the
  • the field induced inside the cell is substantially homogenous.
  • negative electrode 32 also refe ⁇ ed to herein as "sink”
  • electrodes 28 and 32 are electrically insulated.
  • insulated electrodes applying a DC or
  • insulated electrodes in contrast, always generate some form of cu ⁇ ent flow, specifically,
  • nuclei 24 and 26 of sub-cells 14 and 16, respectively are polarizable and, thus,
  • organelles 24 and 26 may have a "hammering" effect
  • pulsed forces beat on the intracellular organelles at a desired rhythm, e.g., a pre ⁇
  • a field normal to the longitudinal axis of bridge 22 i.e., a field normal to the longitudinal axis of bridge 22 (i.e., a field normal to the longitudinal axis of bridge 22 (i.e., a field normal to the longitudinal axis of bridge 22 (i.e., a field normal to the longitudinal axis of bridge 22 (i.e., a field normal to the longitudinal axis of bridge 22 (i.e.,
  • potential applied to the tissue being treated is rotated relative to the tissue.
  • epithelial cells divide generally only in a specific orientation
  • tumor which grows at a relatively moderate rate e.g., a tumor that doubles its volume in
  • this method causes substantially no damage to non-dividing cells, this method may
  • Shielding may be preformed by positioning conducting materials,
  • the field may be selectively applied to specific target
  • the electrodes may be inserted into the body and brought to a
  • electric fields may be generated in the body by
  • Fig. 4 presents a number of sequential microphotographic frames taken over a
  • predetermined time period showing typical cell division when no electric field is applied.
  • the cells are BHK (baby hamster kidney) cells.
  • microphotography was taken over a 40 minute period.
  • the cells were cultured in a
  • DMEM standard culture medium
  • A shows the location of a dividing cell prior to the division process.
  • a non-dividing cell is normally flattened on the tissue culture plate. In this state, the cell can not be
  • frame C in frame C and proceeds to take on an hourglass-like shape, as shown in frame D.
  • frame D In frame
  • Fig. 5 presents a number of sequential microphotographic frames taken over a
  • Fig. 5 shows the a ⁇ ested division of BHK cells when an
  • the intensity of the electric field was 78 V/cm
  • the cell is bulging from the plate and has a cleft. After almost 40 minutes,
  • tumor refers to a malignant tissue comprising
  • Tumors include leukemias, lymphomas, and
  • sarcomas and carcinomas such as, but not
  • fibrosarcoma myxosarcoma, liposarcoma, chondrosarcoma, osteogenic
  • sarcoma chordoma
  • angiosarcoma endotheliosarcoma
  • lymphangiosarcoma lymphangiosarcoma
  • lymphangioendotheliosarcoma synovioma
  • mesothelioma mesothelioma
  • Ewing's tumor
  • ovarian cancer prostate cancer, squamous cell carcinoma, basal cell carcinoma,
  • adenocarcinoma sweat gland carcinoma, sebaceous gland carcinoma, papillary carcinoma
  • carcinoma renal cell carcinoma, hepatoma, bile duct carcinoma, choriocarcinoma,
  • carcinoma small cell lung carcinoma, bladder carcinoma, epithelial carcinoma, glioma,
  • hemangioblastoma hemangioblastoma, acoustic neuroma, oligodendroglioma, meningioma, melanoma,
  • any one can be treated in accordance with the invention.
  • the invention is particularly advantageous for treating brain tumors, which are difficult to treat with
  • the present invention is suitable for use in treating skin and breast tumors because
  • the present invention can control uncontrolled growth associated with
  • the tissue undergoing inappropriate growth For example, it is contemplated that the
  • AV arterio venous
  • the invention may also be used to treat psoriasis, a dermatologic
  • prostatic hypertrophy a condition associated with inflammation and possibly vascular
  • the present invention provides an effective, simple method of selectively
  • dividing cells e.g., tumor cells and parasitic organisms
  • the present invention does not damage the normal cells or organisms.
  • the present invention does not damage the normal cells or organisms.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PCT/IB2001/000202 2000-02-17 2001-02-16 Method and apparatus for destroying dividing cells Ceased WO2001060994A1 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
CA2400526A CA2400526C (en) 2000-02-17 2001-02-16 Method and apparatus for destroying dividing cells
US10/204,334 US7333852B2 (en) 2000-02-17 2001-02-16 Method and apparatus for destroying dividing cells
JP2001560365A JP5280600B2 (ja) 2000-02-17 2001-02-16 分裂中の細胞を破壊するための方法および装置
EP01906036A EP1259596A4 (en) 2000-02-17 2001-02-16 METHOD AND DEVICE FOR DESTROYING DIVIDING CELLS
US12/199,498 USRE43618E1 (en) 2000-02-17 2001-02-16 Method and apparatus for destroying dividing cells
AU33998/01A AU3399801A (en) 2000-02-17 2001-02-16 Method and apparatus for destroying dividing cells
US11/111,236 US7805201B2 (en) 2000-02-17 2005-04-21 Treating a tumor or the like with an electric field
US11/111,439 US7565205B2 (en) 2000-02-17 2005-04-21 Treating a tumor or the like with electric fields at different orientations
US11/111,393 US7599745B2 (en) 2000-02-17 2005-04-21 Treating a tumor or the like with an electric field
US11/318,702 US7565206B2 (en) 2000-02-17 2005-12-27 Treating a tumor or the like with electric fields at different orientations
US11/422,641 US7599746B2 (en) 2000-02-17 2006-06-07 Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases
US12/146,918 US8175698B2 (en) 2000-02-17 2008-06-26 Treating bacteria with electric fields
US12/190,886 US7890183B2 (en) 2000-02-17 2008-08-13 Treating parasites with electric fields
US12/958,623 US8447395B2 (en) 2000-02-17 2010-12-02 Treating bacteria with electric fields
US13/428,887 US8447396B2 (en) 2000-02-17 2012-03-23 Treating bacteria with electric fields
US13/782,418 US9039674B2 (en) 2000-02-17 2013-03-01 Treating bacteria with electric fields
US13/782,579 US9056203B2 (en) 2000-02-17 2013-03-01 Treating bacteria with electric fields
US14/731,903 US9440068B2 (en) 2000-02-17 2015-06-05 Treating bacteria with electric fields
US15/231,734 US9750934B2 (en) 2000-02-17 2016-08-08 Treating bacteria with electric fields

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18329500P 2000-02-17 2000-02-17
US60/183,295 2000-02-17

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/288,562 Continuation-In-Part US7016725B2 (en) 2000-02-17 2002-11-05 Method and apparatus for destroying dividing cells

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US10/204,334 A-371-Of-International US7333852B2 (en) 2000-02-17 2001-02-16 Method and apparatus for destroying dividing cells
US10204334 A-371-Of-International 2001-02-16
US10/402,327 Continuation-In-Part US7146210B2 (en) 2000-02-17 2003-03-28 Apparatus and method for optimizing tumor treatment efficiency by electric fields

Publications (1)

Publication Number Publication Date
WO2001060994A1 true WO2001060994A1 (en) 2001-08-23

Family

ID=22672230

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/000202 Ceased WO2001060994A1 (en) 2000-02-17 2001-02-16 Method and apparatus for destroying dividing cells

Country Status (7)

Country Link
US (2) USRE43618E1 (https=)
EP (2) EP2335776A1 (https=)
JP (1) JP5280600B2 (https=)
CN (1) CN1416466A (https=)
AU (1) AU3399801A (https=)
CA (1) CA2400526C (https=)
WO (1) WO2001060994A1 (https=)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004030760A3 (en) * 2002-10-02 2004-07-22 Standen Ltd Apparatus for treating a tumor by an electric field
US7016725B2 (en) 2001-11-06 2006-03-21 Standen Ltd. Method and apparatus for destroying dividing cells
US7089054B2 (en) 2002-10-02 2006-08-08 Standen Ltd. Apparatus and method for treating a tumor or the like
US7136699B2 (en) 2002-10-02 2006-11-14 Standen, Ltd. Apparatus for destroying dividing cells
US7146210B2 (en) 2000-02-17 2006-12-05 Standen Ltd. Apparatus and method for optimizing tumor treatment efficiency by electric fields
US7333852B2 (en) 2000-02-17 2008-02-19 Standen Ltd. Method and apparatus for destroying dividing cells
JP2008525080A (ja) * 2004-12-27 2008-07-17 スタンデン・リミテッド 異なる配向の電界を用いて腫瘍またはその類似物を処理する方法
WO2008098298A1 (en) * 2007-02-16 2008-08-21 Iogenyx Pty Ltd Methods for improving the cultivation of aquatic organisms
US7565205B2 (en) 2000-02-17 2009-07-21 Standen Ltd. Treating a tumor or the like with electric fields at different orientations
US7599746B2 (en) 2000-02-17 2009-10-06 Standen Ltd Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases
US7715921B2 (en) 2004-12-07 2010-05-11 Standen Ltd. Electrodes for applying an electric field in-vivo over an extended period of time
US7890183B2 (en) 2000-02-17 2011-02-15 Novocure Ltd. Treating parasites with electric fields
US7917227B2 (en) 2005-10-03 2011-03-29 Standen Ltd. Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
US8019414B2 (en) 2006-04-05 2011-09-13 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
US8175698B2 (en) 2000-02-17 2012-05-08 Novocure Ltd. Treating bacteria with electric fields
US8447395B2 (en) 2000-02-17 2013-05-21 Novocure Ltd Treating bacteria with electric fields
US8465533B2 (en) 2007-03-06 2013-06-18 Novocure Limited Treating cancer using electromagnetic fields in combination with photodynamic therapy
US11941761B2 (en) 2019-12-31 2024-03-26 Novocure Gmbh Methods, systems, and apparatuses for image segmentation
US12115381B2 (en) 2019-12-02 2024-10-15 Novocure Gmbh Methods, systems, and apparatuses for optimizing transducer array placement
US12367961B2 (en) 2019-12-31 2025-07-22 Novocure Gmbh Methods, systems, and apparatuses for fast approximation of electric field distribution

Families Citing this family (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070021803A1 (en) 2005-07-22 2007-01-25 The Foundry Inc. Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction
WO2008034103A2 (en) * 2006-09-14 2008-03-20 Lazure Technologies, Llc Device and method for destruction of cancer cells
US8562602B2 (en) * 2007-09-14 2013-10-22 Lazure Technologies, Llc Multi-layer electrode ablation probe and related methods
CN105232148A (zh) * 2007-09-14 2016-01-13 拉热尔技术有限公司 前列腺癌消融
US20090076500A1 (en) * 2007-09-14 2009-03-19 Lazure Technologies, Llc Multi-tine probe and treatment by activation of opposing tines
US20100100093A1 (en) * 2008-09-16 2010-04-22 Lazure Technologies, Llc. System and method for controlled tissue heating for destruction of cancerous cells
US8728139B2 (en) 2009-04-16 2014-05-20 Lazure Technologies, Llc System and method for energy delivery to a tissue using an electrode array
US9526911B1 (en) 2010-04-27 2016-12-27 Lazure Scientific, Inc. Immune mediated cancer cell destruction, systems and methods
US9233257B1 (en) 2010-11-22 2016-01-12 Jacob Zabara Electromagnetic radiation treatment
US8684901B1 (en) 2010-11-22 2014-04-01 Jacob Zabara Electromagnetic radiation treatment for cancer and pathological genetic regulations
US9031701B2 (en) 2011-02-15 2015-05-12 Hemosonics Llc Characterization of blood hemostasis and oxygen transport parameters
US9789328B2 (en) * 2012-10-26 2017-10-17 Robert E. Sandstrom Tumor treatment with free radical lifetimes enhanced by persistent low strength magnetic field
US9757582B2 (en) * 2012-10-26 2017-09-12 Robert E. Sandstrom Tumor treatment with free radical lifetimes enhanced by persistant low strength magnetic field
US10779875B2 (en) 2013-05-06 2020-09-22 Novocure Gmbh Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment
US9655669B2 (en) 2013-05-06 2017-05-23 Novocure Limited Optimizing treatment using TTFields by changing the frequency during the course of long term tumor treatment
US9833617B2 (en) 2014-07-25 2017-12-05 Loyalty Based Innovations, LLC Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields
US20190117963A1 (en) 2014-07-25 2019-04-25 Loyalty Based Innovations, LLC Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields
US9726647B2 (en) 2015-03-17 2017-08-08 Hemosonics, Llc Determining mechanical properties via ultrasound-induced resonance
US10188851B2 (en) 2015-10-28 2019-01-29 Novocure Limited TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements
US10821283B2 (en) 2016-04-04 2020-11-03 Novocure Gmbh Reducing motility of cancer cells using tumor treating fields (TTFields)
US20180001075A1 (en) 2016-06-30 2018-01-04 Novocure Limited Arrays for Longitudinal Delivery of TTFields to a Body
EP3571503B1 (en) 2017-01-19 2026-04-15 Novocure GmbH System for viewing cell cultures under a microscope whilst applying ttfields
US11338135B2 (en) 2017-10-23 2022-05-24 Cardiac Pacemakers, Inc. Medical devices for cancer therapy with electric field shaping elements
US12403306B2 (en) 2017-10-23 2025-09-02 Cardiac Pacemakers, Inc. Electric field shaping leads for treatment of cancer
CO2018001283A1 (es) 2018-02-07 2019-08-09 Panacea Quantum Leap Tech Llc Método de estimulación de tejidos con campos eléctricos y magnéticos por barrido en frecuencia
US10953209B2 (en) 2018-03-28 2021-03-23 Board Of Regents Of The University Of Texas System Treating tumors using TTFields combined with a PARP inhibitor
US11298422B2 (en) 2018-04-09 2022-04-12 Novocure Gmbh Treating tumors with TTFields and an aurora kinase inhibitor
WO2019197999A1 (en) 2018-04-10 2019-10-17 Zeev Bomzon Low frequency (<1 mhz) ac conductivity estimates derived from two mri images having different repetition times
KR102870236B1 (ko) 2018-07-03 2025-10-14 에드윈 창 세포막 투과성을 향상시키기 위한 교류 전기장 사용
BR112020025692A2 (pt) 2018-07-10 2021-03-16 Novocure Gmbh Inibição de infecção viral usando campos elétricos alternados
US11179322B2 (en) 2018-07-10 2021-11-23 Novocure Gmbh Methods and compositions for treating tumors with TTFields and sorafenib
EP3967361A1 (en) 2018-07-18 2022-03-16 Novocure GmbH Using power loss density and related measures to quantify the dose of tumor treating fields
DK3804648T3 (da) 2018-08-23 2022-04-11 Novocure Gmbh Anvendelse af elektriske vekseltrømsfelter til forøgelse af permeabilitet af blodhjernebarrieren
US11160977B2 (en) 2018-09-04 2021-11-02 Novocure Gmbh Delivering tumor treating fields (TTFields) to the infratentorial brain
US11986647B2 (en) 2018-09-07 2024-05-21 Novocure Gmbh Treating autoinflammatory and mitochondrial diseases using an alternating electric field
EP3846894B8 (en) 2018-09-07 2025-06-18 Novocure GmbH Treating autoimmune diseases using an alternating electric field to reduce the proliferation of t-cells
PL3984590T3 (pl) 2018-10-15 2023-05-02 Novocure Gmbh Wytwarzanie pól leczących guzy (pól elektrycznych do leczenia nowotworów ttfields) o wysokiej równomierności w całym mózgu
CN112955208B (zh) * 2018-10-25 2024-11-22 诺沃库勒有限责任公司 向受试者的脊柱解剖结构递送交变电场(例如，ttfields)的方法
EP3880299B1 (en) 2018-11-13 2025-09-24 The Methodist Hospital Device for oncomagnetic treatment
CN113015553B (zh) 2018-11-19 2025-01-14 诺沃库勒有限责任公司 用于递送具有选择性可寻址子元件的肿瘤治疗场（TTField）的阵列
BR112021004336A2 (pt) 2018-11-29 2021-08-17 Novocure Gmbh matrizes de transdutor com flexibilidade melhorada para entregar ttfields (campos de tratamento de tumor)
EP3968279B1 (en) 2019-01-08 2025-01-01 Novocure GmbH Evaluating quality of segmentation of an image into different types of tissue for planning treatment using tumor treating fields (ttfields)
US11554262B2 (en) 2019-02-26 2023-01-17 Novocure Gmbh Determining a frequency for TTFields treatment based on an electrical characteristic of targeted cancer cells
EP4491214B1 (en) 2019-02-27 2026-01-21 Novocure GmbH Delivering tumor treating fields (ttfields) using implantable transducer arrays
JP7419391B2 (ja) 2019-03-29 2024-01-22 ノボキュア ゲーエムベーハー ＰＴＧＥＲ３阻害剤によりＴＴＦｉｅｌｄｓ－耐性がん細胞におけるＴＴＦｉｅｌｄｓに対する感受性を回復させるための方法
ES2940749T3 (es) 2019-04-17 2023-05-11 Novocure Gmbh Carga de datos desde un sistema aislado sin comprometer el aislamiento
EP4480526A3 (en) 2019-04-22 2025-03-12 Boston Scientific Scimed, Inc. Combination electrical and chemotherapeutic treatment of cancer
EP3958954B1 (en) 2019-04-22 2024-04-24 Boston Scientific Scimed Inc. Electrical stimulation devices for cancer treatment
CN113766949B (zh) 2019-04-22 2025-04-08 波士顿科学国际有限公司 用于施用电刺激以治疗癌症的系统
CN113766950A (zh) 2019-04-23 2021-12-07 波士顿科学国际有限公司 带有热治疗或热监测的电刺激
US11850422B2 (en) 2019-04-23 2023-12-26 Boston Scientific Scimed, Inc. Electrodes for electrical stimulation to treat cancer
WO2020219517A2 (en) 2019-04-23 2020-10-29 Boston Scientific Scimed, Inc. Electrical stimulation for cancer treatment with internal and external electrodes
CN121314073A (zh) 2019-07-31 2026-01-13 诺沃库勒有限责任公司 经由埋入颅骨植入物中的电极施加肿瘤治疗场（TTField）
WO2021024170A1 (en) 2019-08-05 2021-02-11 Voloshin Sela Tali Increasing cancer cells' sensitivity to tumor treating fields (ttfields) by inhibiting il11 activity
CN114364433A (zh) 2019-08-30 2022-04-15 诺沃库勒有限责任公司 向颈部输送肿瘤治疗场（TTFields）
JP7453355B2 (ja) 2019-09-30 2024-03-19 テーデーカー エレクトロニクス アーゲー 多結晶セラミック固体、該固体による誘電体電極、該電極を備える装置及び製造方法
WO2021092402A1 (en) 2019-11-08 2021-05-14 Novocure Gmbh Perforated hydrogel configurations and methods of production and use thereof
US12121739B2 (en) 2019-12-31 2024-10-22 Novocure Gmbh Methods, systems, and apparatuses for managing temperatures induced by alternating fields
CN121695416A (zh) 2019-12-31 2026-03-20 诺沃库勒有限责任公司 具有可单独访问的电极元件和温度传感器的用于传递肿瘤治疗场（tt场）的阵列
CN121314067A (zh) 2019-12-31 2026-01-13 诺沃库勒有限责任公司 防止幅度调整和信道切换期间的尖峰的高电压、高效率正弦波生成器
TWI864225B (zh) 2020-01-22 2024-12-01 瑞士商諾沃庫勒有限責任公司 用於ｔｔｆｉｅｌｄ生成系統之組件及換能器陣列
US11883655B2 (en) 2020-02-24 2024-01-30 Boston Scientific Scimed, Inc. Systems and methods for treatment of pancreatic cancer
US20210299440A1 (en) 2020-03-30 2021-09-30 Novocure Gmbh Intravenous / Intra-Spinal / Intra-Cavity / Intraventricular Delivery of TTFields (Tumor Treating Fields) for Treating Cancer and Metastases
BR112022021484A2 (pt) 2020-04-24 2022-12-13 Novocure Gmbh Uso de campos elétricos alternados para aumentar a permeabilidade da barreira hematoencefálica
WO2021223684A1 (zh) * 2020-05-02 2021-11-11 电冷科学有限公司 一种避免活性非消融电极附近组织损伤的装置
TWI889816B (zh) 2020-05-06 2025-07-11 瑞士商諾沃庫勒有限責任公司 用於產生腫瘤治療電場之導電襯墊以及生產和使用其之方法
EP4168108A4 (en) 2020-06-19 2024-07-17 The Methodist Hospital dba Houston Methodist Hospital METHOD AND APPARATUS FOR ONCOMAGNETIC TREATMENT
US11818943B2 (en) 2020-06-25 2023-11-14 Novocure Gmbh Fabricating organic light emitting diodes (OLEDs) using tubulin
CA3187793A1 (en) * 2020-08-03 2022-02-10 Novocure Gmbh Compositions and methods for increasing cancer cell sensitivity to alternating electric fields
CN114075508A (zh) * 2020-08-14 2022-02-22 上海必修福企业管理有限公司 电场发生装置及其在影响细胞的分裂周期中的用途和方法
EP4223364B1 (en) 2020-09-25 2024-04-24 Novocure GmbH Varying the metallization area on individual electrode elements in a tumor treating fields system to maximize current without overheating
DE102020133165B9 (de) 2020-12-11 2024-06-06 Tdk Electronics Ag Keramikelektrode, Baugruppe mit der Keramikelektrode, Anordnung mit der Keramikelektrode und Verfahren zur Herstellung einer Keramikelektrode
EP4282465B1 (en) 2020-12-21 2025-07-23 Novocure GmbH Optimization of composite electrode
US12397151B2 (en) 2021-02-17 2025-08-26 Novocure Gmbh Arrays for delivering tumor treating fields (TTFields) with sets of electrode elements having individually adjustable active areas
US12440680B2 (en) 2021-03-12 2025-10-14 Novocure Gmbh Methods of treating disease by skewing macrophage phenotype with alternating electric fields
EP4480527B1 (en) 2021-03-12 2025-11-05 Novocure GmbH An electrode array
JP2024515452A (ja) 2021-03-18 2024-04-10 ノボキュア ゲーエムベーハー 液体ハイドロゲルによって３ｄファントムを構築すること
EP4284489B1 (en) 2021-03-31 2025-07-16 Novocure Gmbh Impedance tomography using electrodes of a tumor treating fields (ttfields) system
WO2023275749A1 (en) 2021-06-30 2023-01-05 Novocure Gmbh Using capacitors to regulate current in transducer arrays for applying tumor treating fields (ttfields)
EP4344413B1 (en) 2021-07-21 2025-05-28 Novocure GmbH Conductive pad generating tumor treating field
US11877838B2 (en) * 2021-08-14 2024-01-23 Nano Hesgarsazan Salamat Arya Preventing cytokine storm in COVID-19 patients by suppressing clonal expansion in activated lymphocytes using alternating electric fields
WO2023042080A1 (en) 2021-09-14 2023-03-23 Novocure Gmbh Temperature independent method and system for applying ttfields
US12527954B2 (en) 2021-09-30 2026-01-20 Novocure Gmbh Method and system for applying tumor treating fields interfacing with hair follicles
WO2023095111A1 (en) 2021-11-29 2023-06-01 Novocure Gmbh Methods of reducing ciliogenesis with alternating electric fields
US20230173288A1 (en) 2021-12-07 2023-06-08 Novocure Gmbh Compact dc system for delivering a square wave ac signal
EP4649993A3 (en) 2021-12-10 2025-12-31 Novocure GmbH COMPRESSION GARMENT SET FOR APPLYING TT FIELDS
US12434051B2 (en) 2021-12-10 2025-10-07 Novocure Gmbh Compression garment assembly for applying TTFields and methods of production and use thereof
US20230173265A1 (en) 2021-12-10 2023-06-08 Novocure Gmbh Garment providing a biasing force on a transducer array
MX2024006036A (es) 2021-12-14 2024-06-05 Novocure Gmbh Desplazamiento de matriz de transductores para reducir la irritacion cutanea.
TW202333820A (zh) 2021-12-29 2023-09-01 瑞士商諾沃庫勒有限責任公司 在使用交流電場治療受試者時藉由使用較大陰極和較小陽極來降低電知覺
JP2024545019A (ja) 2021-12-30 2024-12-05 ノボキュア ゲーエムベーハー 腫瘍治療フィールド（ｔｔｆｉｅｌｄ）を使用した治療のためのパラメータ値の選択
US12478779B2 (en) 2022-03-29 2025-11-25 Novocure Gmbh Electrode array having a semi-liquid conductive gel
JP7710117B2 (ja) 2022-03-30 2025-07-17 ノボキュア ゲーエムベーハー トランスデューサアレイをペアリングすることによる交流電場を用いた被験者の治療および電気感覚の軽減
EP4460361B1 (en) 2022-03-30 2025-03-19 Novocure GmbH Using interleaved cooling periods to increase the peak intensity of tumor treating fields
US12420113B2 (en) 2022-04-01 2025-09-23 The Board Of Regents Of The University Of Texas System Methods and apparatus for applying tumor treating fields combined with personalized ultra-fractionated stereotactic adaptive radiotherapy
WO2023242741A1 (en) 2022-06-13 2023-12-21 Novocure Gmbh Systems and methods for increasing intestinal absorption of therapeutic agents
EP4539924A1 (en) 2022-06-20 2025-04-23 Novocure GmbH Compositions, systems, and methods for treating cancer using tumor treating fields and vegf inhibitors
JP2025520663A (ja) 2022-06-21 2025-07-03 ノボキュア ゲーエムベーハー 交流電場とｃｒｉｓｐｒ－ｃａｓシステムを用いた症状および疾患の治療システムおよび方法
US20240081939A1 (en) 2022-09-08 2024-03-14 Novocure Gmbh Constructing a 3d phantom with a matrix material having conductive particles dispersed therein
CN119947782A (zh) 2022-09-27 2025-05-06 诺沃库勒有限责任公司 用于测量内部TTField强度的可摄入且可植入的装置
CA3180284A1 (en) 2022-09-29 2024-03-29 Novocure Gmbh Transducer array having a temperature sensor isolation layer between a temperature sensor and external environment
JP2025532765A (ja) 2022-09-29 2025-10-03 ノボキュア ゲーエムベーハー 電池交換中にｔｔ場を維持するためのシステムおよび方法
CN119968209A (zh) 2022-09-30 2025-05-09 诺沃库勒有限责任公司 使用交变电场和树突状细胞治疗癌症的组合物、系统和方法
US20240108704A1 (en) 2022-09-30 2024-04-04 Novocure Gmbh Compositions, systems, and methods for treating cancer using alternating electric fields and apoptotic cancer cell vaccination
EP4554658A1 (en) 2022-09-30 2025-05-21 Novocure Gmbh Single wire temperature measurement solution for a ttfield application system and methods of production and use thereof
US20240108699A1 (en) 2022-09-30 2024-04-04 Novocure Gmbh Compositions, systems, and methods for reducing electrosensation and/or skin irritation
CN115845254B (zh) * 2022-11-23 2024-02-02 湖南安泰康成生物科技有限公司 小细胞肺癌治疗系统以及交变电场发生装置
IL320472A (en) 2022-11-30 2025-06-01 Novocure Gmbh Transducer arrays with alternative array materials
WO2024127192A1 (en) 2022-12-13 2024-06-20 Novocure Gmbh Wireless transducer arrays applying tumor treating fields and systems and methods of use thereof
IL320470A (en) 2022-12-28 2025-06-01 Novocure Gmbh Compositions, systems and methods for treating cancer using tumor-treating fields and anti-VEGFR-2 antibodies
US12268863B2 (en) 2023-02-06 2025-04-08 Novocure Gmbh Shiftable transducer array with anisotropic material layer
WO2024201344A1 (en) 2023-03-30 2024-10-03 Novocure Gmbh Compositions, systems, and methods for treating cancer using tumor treating fields and chimeric antigen receptor (car)-immune cells
CN120936370A (zh) 2023-03-30 2025-11-11 诺沃库勒有限责任公司 用于使用肿瘤治疗电场和杀伤细胞治疗癌症的组合物、系统和方法
US20240399141A1 (en) 2023-03-31 2024-12-05 Novocure Gmbh Microneedles to overcome contact resistance
US20240415869A1 (en) 2023-06-15 2024-12-19 Novocure Gmbh Compositions, systems, and methods for treating cancer using tumor treating fields (ttfields) and thioredoxin/glutathione inhibitors
WO2025062369A1 (en) 2023-09-21 2025-03-27 Novocure Gmbh Compositions, systems, and methods for treating cancer using tumor treating fields with immune checkpoint inhibitors and mhc class i activators
TW202529847A (zh) 2023-09-28 2025-08-01 瑞士商諾沃庫勒有限責任公司 具有子陣列的換能器陣列及其製造和使用方法
WO2025068924A1 (en) 2023-09-29 2025-04-03 Novocure Gmbh Using staggered changes in amplitude and frequency to ameliorate electrosensation during treatment with alternating electric fields
WO2025068918A1 (en) 2023-09-29 2025-04-03 Novocure Gmbh Apparatus and method of reapplying transducer arrays to a patient
CN121925227A (zh) 2023-09-29 2026-04-24 诺沃库勒有限责任公司 低频射频消融系统
WO2025088586A1 (en) 2023-10-27 2025-05-01 Brown University Compositions, systems, and methods for treating cancer using tumor treating fields with inhibitors of mif, mica, and/or micb
US20250281446A1 (en) 2024-03-05 2025-09-11 Novocure Gmbh Compositions, systems, and methods for treating cancer in standard of care and/or profibrotic chemotherapeutic agent-naïve patients using tumor treating fields and chemotherapeutic agents
US20250288820A1 (en) 2024-03-15 2025-09-18 Novocure Gmbh Reduced impedance transducer array for applying alternating electric fields and methods of production and use thereof
US20250367138A1 (en) 2024-05-31 2025-12-04 Novocure Gmbh Compositions, systems, and methods for treating cancer using tumor treating fields (ttfields) and methylglyoxal
WO2026003783A1 (en) 2024-06-27 2026-01-02 Novocure Gmbh Compositions, systems, and methods for treating cancer using tumor treating fields (ttfields) and nf-κb inhibitors
US20260034376A1 (en) 2024-08-05 2026-02-05 Novocure Gmbh Shiftable transducer array with anisotropic material layer and foam layer
WO2026033423A1 (en) 2024-08-05 2026-02-12 Novocure Gmbh Flexible layer for use in a tumor treating fields transducer
WO2026062559A1 (en) 2024-09-20 2026-03-26 Novocure Gmbh Compositions, systems, and methods for treating cancer using tumor treating fields (ttfields) and interferon gamma
WO2026069010A1 (en) 2024-09-25 2026-04-02 Novocure Gmbh Compositions and systems for treating cancer using tumor treating fields (ttfields) and ace inhibitors
WO2026069112A1 (en) 2024-09-26 2026-04-02 Novocure Gmbh Compositions, systems, and methods for treating cancer using tumor treating fields, chemotherapeutic agents, and anti-fibrotic agents
WO2026069265A1 (en) 2024-09-30 2026-04-02 Novocure Gmbh Transducer array generating tumor treating field

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312813A (en) * 1991-05-03 1994-05-17 University Technologies International Biofilm reduction method

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR446660A (fr) 1911-09-02 1912-12-12 Gottlieb Schuettel Dispositif pour métiers continus à anneaux pour monter les curseurs sur les anneaux
BE794566A (fr) 1972-01-28 1973-07-26 Esb Inc Regenerateur et stimulateur bioelectrochimique et procedes d'application in vivo d'energie electrique a des cellules et des tissus.
US3991770A (en) 1974-01-24 1976-11-16 Leveen Harry H Method for treating benign and malignant tumors utilizing radio frequency, electromagnetic radiation
US4016886A (en) 1974-11-26 1977-04-12 The United States Of America As Represented By The United States Energy Research And Development Administration Method for localizing heating in tumor tissue
US4121592A (en) 1975-08-04 1978-10-24 Critical Systems, Inc. Apparatus for heating tissue
DE2907013A1 (de) 1978-02-24 1979-08-30 American Med Syst Verfahren und vorrichtung zum beguenstigen der heilung von verletzten knochenknorpeln und geweben im gesichtsbereich
DE2813068A1 (de) 1978-03-25 1979-10-04 Philips Patentverwaltung Verfahren und vorrichtung zur ermittlung von inneren koerperstrukturen
GB2043453A (en) 1979-02-22 1980-10-08 Electrochem Tech Corp Improvements in or relating to an electrode
US4472506A (en) 1981-01-13 1984-09-18 Liburdy Robert P Method for determining cell membrane dielectric breakdown
US4467809A (en) 1982-09-17 1984-08-28 Biolectron, Inc. Method for non-invasive electrical stimulation of epiphyseal plate growth
US4622952A (en) 1983-01-13 1986-11-18 Gordon Robert T Cancer treatment method
CA1244889A (en) 1983-01-24 1988-11-15 Kureha Chemical Ind Co Ltd HYPERTHERMIA DEVICE
DE3323415C2 (de) * 1983-06-29 1985-04-25 Kernforschungsanlage Jülich GmbH, 5170 Jülich Verwendung eines Verfahrens und einer Vorrichtung zur Bestimmung von Zellinhaltstoffe sezernierenden Zellen
SE455920B (sv) 1986-01-29 1988-08-22 Hans Wiksell Anordning for hypertermibehandling av tumorer
US4923814A (en) 1986-05-09 1990-05-08 Electropore, Inc. High speed, high power apparatus for vesicle prealignment, poration, loading and fusion in uniform electric fields and method therefor
CN86103803B (zh) 1986-06-05 1987-11-18 北京信息工程学院 静电场治疗装置
US4822470A (en) * 1987-10-09 1989-04-18 Baylor College Of Medicine Method of and apparatus for cell poration and cell fusion using radiofrequency electrical pulses
US4936303A (en) 1987-11-20 1990-06-26 Ultrathermics Ultrasonic heating apparatus and method
JPH0629196B2 (ja) 1987-12-01 1994-04-20 甲子郎 梅村 超音波による腫瘍治療用生理作用増強剤
US5389069A (en) 1988-01-21 1995-02-14 Massachusetts Institute Of Technology Method and apparatus for in vivo electroporation of remote cells and tissue
FR2627987B3 (fr) 1988-03-04 1990-02-02 Indiba Sa Appareil electronique pour la therapie medicale et cosmetique
US5158071A (en) 1988-07-01 1992-10-27 Hitachi, Ltd. Ultrasonic apparatus for therapeutical use
GB8904998D0 (en) 1989-03-04 1989-04-19 Matthews Tony Anaesthetising apparatus
US5099756A (en) 1989-06-01 1992-03-31 Harry H. Leveen Radio frequency thermotherapy
US5441746A (en) 1989-12-22 1995-08-15 Molecular Bioquest, Inc. Electromagnetic wave absorbing, surface modified magnetic particles for use in medical applications, and their method of production
US5236410A (en) 1990-08-02 1993-08-17 Ferrotherm International, Inc. Tumor treatment method
AU9027191A (en) * 1990-11-05 1992-05-26 Bsd Medical Corporation Urethral inserted applicator for prostate hyperthermia
US5441532A (en) 1991-06-26 1995-08-15 Massachusetts Institute Of Technology Adaptive focusing and nulling hyperthermia annular and monopole phased array applicators
US5697909A (en) * 1992-01-07 1997-12-16 Arthrocare Corporation Methods and apparatus for surgical cutting
US5468223A (en) 1992-11-30 1995-11-21 C.N.R.S. Paris Electrochemotherapy
US5386837A (en) 1993-02-01 1995-02-07 Mmtc, Inc. Method for enhancing delivery of chemotherapy employing high-frequency force fields
FR2703253B1 (fr) 1993-03-30 1995-06-23 Centre Nat Rech Scient Applicateur d'impulsions electriques pour traitement de tissus biologiques.
US5458597A (en) * 1993-11-08 1995-10-17 Zomed International Device for treating cancer and non-malignant tumors and methods
IL108775A (en) 1994-02-25 2003-09-17 Univ Ramot Method for efficient incorporation of molecules into cells
US5704355A (en) 1994-07-01 1998-01-06 Bridges; Jack E. Non-invasive system for breast cancer detection
WO1997004830A1 (en) 1995-07-28 1997-02-13 Gray James R Use of a polarizing field to modify the efficacy of a bioactive agent
US5606971A (en) 1995-11-13 1997-03-04 Artann Corporation, A Nj Corp. Method and device for shear wave elasticity imaging
US5718246A (en) 1996-01-03 1998-02-17 Preferential, Inc. Preferential induction of electrically mediated cell death from applied pulses
US5984882A (en) 1996-08-19 1999-11-16 Angiosonics Inc. Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy
US5869326A (en) 1996-09-09 1999-02-09 Genetronics, Inc. Electroporation employing user-configured pulsing scheme
US6055453A (en) 1997-08-01 2000-04-25 Genetronics, Inc. Apparatus for addressing needle array electrodes for electroporation therapy
US6043066A (en) 1997-09-04 2000-03-28 Mangano; Joseph A. Cell separation using electric fields
US6027488A (en) 1998-06-03 2000-02-22 Genetronics, Inc. Flow-through electroporation system for ex vivo gene therapy
US5976092A (en) 1998-06-15 1999-11-02 Chinn; Douglas O. Combination stereotactic surgical guide and ultrasonic probe
US6319901B1 (en) 1998-10-15 2001-11-20 Ichor Medical Systems, Inc. Methods for prolonging cell membrane permeability
CA2364098C (en) 1999-03-09 2010-11-16 Thermage, Inc. Apparatus and method for treatment of tissue
US6678558B1 (en) * 1999-03-25 2004-01-13 Genetronics, Inc. Method and apparatus for reducing electroporation-mediated muscle reaction and pain response
US6366808B1 (en) 2000-03-13 2002-04-02 Edward A. Schroeppel Implantable device and method for the electrical treatment of cancer
US6853864B2 (en) 2000-02-02 2005-02-08 Catholic University Of America, The Use of electromagnetic fields in cancer and other therapies
US7146210B2 (en) 2000-02-17 2006-12-05 Standen Ltd. Apparatus and method for optimizing tumor treatment efficiency by electric fields
US6868289B2 (en) 2002-10-02 2005-03-15 Standen Ltd. Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor
US7599746B2 (en) 2000-02-17 2009-10-06 Standen Ltd Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases
US7890183B2 (en) 2000-02-17 2011-02-15 Novocure Ltd. Treating parasites with electric fields
JP5280600B2 (ja) 2000-02-17 2013-09-04 パルティ、ヨーラム 分裂中の細胞を破壊するための方法および装置
US7136699B2 (en) 2002-10-02 2006-11-14 Standen, Ltd. Apparatus for destroying dividing cells
US7089054B2 (en) 2002-10-02 2006-08-08 Standen Ltd. Apparatus and method for treating a tumor or the like
US8175698B2 (en) 2000-02-17 2012-05-08 Novocure Ltd. Treating bacteria with electric fields
US7016725B2 (en) 2001-11-06 2006-03-21 Standen Ltd. Method and apparatus for destroying dividing cells
US6546290B1 (en) 2000-04-12 2003-04-08 Roamitron Holding S.A. Method and apparatus for electromedical therapy
US6994706B2 (en) 2001-08-13 2006-02-07 Minnesota Medical Physics, Llc Apparatus and method for treatment of benign prostatic hyperplasia
CA2563817C (en) 2004-04-23 2018-07-10 Yoram Palti Treating a tumor or the like with electric fields at different frequencies
DE102004028156A1 (de) 2004-06-09 2006-01-05 Kalbe, Jochen, Dr. Kombination von Radiowellen mit pharmakologisch aktiven Substanzen
ES2344215T3 (es) 2004-12-07 2010-08-20 Standen Ltd. Electrodos para aplicar un campo electrico in vivo durante un dilatado periodo de tiempo.
EP3666328B1 (en) 2004-12-27 2022-04-06 Novocure GmbH Treating a tumor or the like with electric fields at different orientations
US20060282122A1 (en) 2005-06-08 2006-12-14 Yoram Palti Treating cancer with electric fields that are guided to desired locations within a body
CN101321555B (zh) 2005-10-03 2020-12-08 诺沃库勒有限责任公司 优化电场特征以增加电场在增殖细胞上的效果
US8019414B2 (en) 2006-04-05 2011-09-13 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
US8465533B2 (en) 2007-03-06 2013-06-18 Novocure Limited Treating cancer using electromagnetic fields in combination with photodynamic therapy
US8715203B2 (en) 2007-09-17 2014-05-06 Novocure Limited Composite electrode

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312813A (en) * 1991-05-03 1994-05-17 University Technologies International Biofilm reduction method

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8447395B2 (en) 2000-02-17 2013-05-21 Novocure Ltd Treating bacteria with electric fields
US7599746B2 (en) 2000-02-17 2009-10-06 Standen Ltd Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases
US8447396B2 (en) 2000-02-17 2013-05-21 Novocure Ltd. Treating bacteria with electric fields
USRE43618E1 (en) 2000-02-17 2012-08-28 Novocure Ltd Method and apparatus for destroying dividing cells
US7146210B2 (en) 2000-02-17 2006-12-05 Standen Ltd. Apparatus and method for optimizing tumor treatment efficiency by electric fields
US7333852B2 (en) 2000-02-17 2008-02-19 Standen Ltd. Method and apparatus for destroying dividing cells
US8175698B2 (en) 2000-02-17 2012-05-08 Novocure Ltd. Treating bacteria with electric fields
US7890183B2 (en) 2000-02-17 2011-02-15 Novocure Ltd. Treating parasites with electric fields
US7805201B2 (en) 2000-02-17 2010-09-28 Standen Ltd. Treating a tumor or the like with an electric field
US7599745B2 (en) 2000-02-17 2009-10-06 Standen Ltd Treating a tumor or the like with an electric field
US7565206B2 (en) 2000-02-17 2009-07-21 Standen Ltd. Treating a tumor or the like with electric fields at different orientations
US7565205B2 (en) 2000-02-17 2009-07-21 Standen Ltd. Treating a tumor or the like with electric fields at different orientations
US7016725B2 (en) 2001-11-06 2006-03-21 Standen Ltd. Method and apparatus for destroying dividing cells
EP2281603A3 (en) * 2002-10-02 2011-06-22 Standen Ltd. Apparatus for treating a tumor by an electric field
US7706890B2 (en) 2002-10-02 2010-04-27 Standen Ltd Treating a tumor or the like with an electric field that is focused at a target region
US7089054B2 (en) 2002-10-02 2006-08-08 Standen Ltd. Apparatus and method for treating a tumor or the like
US7467011B2 (en) 2002-10-02 2008-12-16 Standen Ltd Hat for treating a tumor or the like
EP2281604A1 (en) * 2002-10-02 2011-02-09 Standen Ltd. Apparatus for treating a tumor by an electric field
EP2281602A1 (en) * 2002-10-02 2011-02-09 Standen Ltd. Apparatus for treating a tumor by an electric field
EP3659671A1 (en) * 2002-10-02 2020-06-03 Novocure Limited Apparatus for treating a tumor by an electric field
EP2281605A3 (en) * 2002-10-02 2011-06-08 Standen Ltd. Apparatus for treating a tumor by an electric field
EP3656441A1 (en) * 2002-10-02 2020-05-27 Novocure Limited Apparatus for treating a tumor by an electric field
US7912540B2 (en) 2002-10-02 2011-03-22 Standen Ltd. Article of clothing for treating a tumor or the like
US8027738B2 (en) 2002-10-02 2011-09-27 Standen Ltd. Probe for treating a tumor or the like
EP3572123A1 (en) * 2002-10-02 2019-11-27 Novocure Limited Apparatus for treating a tumor by an electric field
WO2004030760A3 (en) * 2002-10-02 2004-07-22 Standen Ltd Apparatus for treating a tumor by an electric field
US7136699B2 (en) 2002-10-02 2006-11-14 Standen, Ltd. Apparatus for destroying dividing cells
US7519420B2 (en) 2002-10-02 2009-04-14 Standen Ltd Apparatus for selectively destroying dividing cells
US8244345B2 (en) 2004-04-23 2012-08-14 Novocure Ltd Treating a tumor or the like with electric fields at different frequencies
US20120283726A1 (en) * 2004-04-23 2012-11-08 Palti Yoram Prof Treating a tumor or the like with electric fields at different frequencies
US8706261B2 (en) 2004-04-23 2014-04-22 Novocure Ltd. Treating a tumor or the like with electric fields at different frequencies
US8170684B2 (en) 2004-12-07 2012-05-01 Novocure Limited Electrodes for applying an electric field in-vivo over an extended period of time
US7715921B2 (en) 2004-12-07 2010-05-11 Standen Ltd. Electrodes for applying an electric field in-vivo over an extended period of time
JP2008525080A (ja) * 2004-12-27 2008-07-17 スタンデン・リミテッド 異なる配向の電界を用いて腫瘍またはその類似物を処理する方法
US8718756B2 (en) 2005-10-03 2014-05-06 Novocure Limited Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
US7917227B2 (en) 2005-10-03 2011-03-29 Standen Ltd. Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
US8406870B2 (en) 2006-04-05 2013-03-26 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
US8019414B2 (en) 2006-04-05 2011-09-13 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
WO2008098298A1 (en) * 2007-02-16 2008-08-21 Iogenyx Pty Ltd Methods for improving the cultivation of aquatic organisms
US8465533B2 (en) 2007-03-06 2013-06-18 Novocure Limited Treating cancer using electromagnetic fields in combination with photodynamic therapy
US12115381B2 (en) 2019-12-02 2024-10-15 Novocure Gmbh Methods, systems, and apparatuses for optimizing transducer array placement
US11941761B2 (en) 2019-12-31 2024-03-26 Novocure Gmbh Methods, systems, and apparatuses for image segmentation
US12131428B2 (en) 2019-12-31 2024-10-29 Novocure Gmbh Methods, systems, and apparatuses for image segmentation
US12367961B2 (en) 2019-12-31 2025-07-22 Novocure Gmbh Methods, systems, and apparatuses for fast approximation of electric field distribution

Also Published As

Publication number Publication date
EP1259596A4 (en) 2004-12-22
EP1259596A1 (en) 2002-11-27
US7333852B2 (en) 2008-02-19
JP5280600B2 (ja) 2013-09-04
CN1416466A (zh) 2003-05-07
EP2335776A1 (en) 2011-06-22
US20030150372A1 (en) 2003-08-14
CA2400526C (en) 2013-04-23
AU3399801A (en) 2001-08-27
USRE43618E1 (en) 2012-08-28
JP2004505604A (ja) 2004-02-26
CA2400526A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
USRE43618E1 (en) Method and apparatus for destroying dividing cells
US7016725B2 (en) Method and apparatus for destroying dividing cells
JP2004505604A5 (https=)
US7565205B2 (en) Treating a tumor or the like with electric fields at different orientations
US7519420B2 (en) Apparatus for selectively destroying dividing cells
CA2696352C (en) Treating parasites with electric fields
US7146210B2 (en) Apparatus and method for optimizing tumor treatment efficiency by electric fields
US8447396B2 (en) Treating bacteria with electric fields
US7565206B2 (en) Treating a tumor or the like with electric fields at different orientations
HK1139089B (en) Treating parasites with electric fields

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2001 560365

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2400526

Country of ref document: CA

REEP Request for entry into the european phase

Ref document number: 2001906036

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 018064167

Country of ref document: CN

Ref document number: 2001906036

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12199498

Country of ref document: US

Ref document number: 10204334

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001906036

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642